Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AP-4 complex subunit epsilon-1 (AP4E1) is a critical component of the heterotetrameric adaptor protein complex 4 (AP-4), which mediates the sorting and transport of transmembrane cargo from the trans-Golgi network to the endosomal-lysosomal system (UniProt, PubMed: 10066790). It plays a vital role in neuronal homeostasis by ensuring the proper localization of proteins such as ATG9A, which is essential for autophagosome biogenesis and autophagic flux (Ma'ayan Lab, PubMed: 26542808). Loss-of-function mutations in the AP4E1 gene are the primary cause of Hereditary Spastic Paraplegia type 51 (SPG51), a neurodevelopmental disorder characterized by progressive spasticity, intellectual disability, and microcephaly (GeneCards, OMIM: 607244). Additionally, heterozygous variants in AP4E1 have been associated with familial persistent stuttering (PubMed: 26542808). While there are currently no approved small-molecule drugs targeting AP4E1, it is a significant focus for gene replacement therapies aimed at restoring AP-4 complex function in affected patients (Open Targets). Research also suggests a potential link between AP-4 deficiency and broader neurodegenerative processes, including Alzheimer's disease (Ma'ayan Lab).
None currently approved; gene replacement therapy is under investigation to restore protein function and AP-4 complex assembly in deficiency syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AP-4 complex subunit epsilon-1 (AP4E1).